佩爾索斯治療公司獲得Xepi乳膏在美國的獨家營銷權Pelthos Therapeutics Secures Exclusive U.S. Marketing Rights for Xepi Cream

動脈網

2025/11/10

by GOAI由GOAI生成Share To分享到Pelthos Therapeutics has acquired the exclusive rights to market Xepi (ozenoxacin) Cream, 1%, in the United States. The product is a non-fluorinated quinolone antimicrobial ...

網頁鏈接

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2582381023"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2582381023\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2582381023?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2025-11-10 18:09","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2582381023","market":"us","top_or_hot":-1,"title":"佩爾索斯治療公司獲得Xepi乳膏在美國的獨家營銷權Pelthos Therapeutics Secures Exclusive U.S. Marketing Rights for Xepi Cream","media":"動脈網","content":"<div>\n<p>by GOAI由GOAI生成Share To分享到Pelthos Therapeutics has acquired the exclusive rights to market Xepi (ozenoxacin) Cream, 1%, in the United States. The product is a non-fluorinated quinolone antimicrobial ...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111018112494fb2a80&s=b\">網頁鏈接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>佩爾索斯治療公司獲得Xepi乳膏在美國的獨家營銷權Pelthos Therapeutics Secures Exclusive U.S. Marketing Rights for Xepi Cream</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n佩爾索斯治療公司獲得Xepi乳膏在美國的獨家營銷權Pelthos Therapeutics Secures Exclusive U.S. Marketing Rights for Xepi Cream\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">動脈網</strong><span class=\"h-time small\">2025-11-10 18:09</span>\n</p>\n</h4>\n</header>\n<article>\n<div>\n<p>by GOAI由GOAI生成Share To分享到Pelthos Therapeutics has acquired the exclusive rights to market Xepi (ozenoxacin) Cream, 1%, in the United States. The product is a non-fluorinated quinolone antimicrobial ...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111018112494fb2a80&s=b\">網頁鏈接</a>\n\n</div>\n\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111018112494fb2a80&s=b\">動脈網</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4539","symbol_name":"半新股","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111018112494fb2a80&s=b","article_id":"2582381023","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111018112494fb2a80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2582381023","pubTimestamp":1762769340,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"此協議授予Pelthos在美國境內對Xepi的分銷和商業化的控制權。Xepi Cream, which contains 1% ozenoxacin, is used as an antimicrobial treatment for skin infections. The acquisition involves transferring marketing rights from Biofrontera and Ferrer to Pelthos Therapeutics, allowing the company to oversee its availability and promotion across the country.含有1%奧澤諾沙星的Xepi乳膏被用作皮膚感染的抗菌治療。此次收購涉及將Xepi的營銷權從Biofrontera和Ferrer轉移至Pelthos Therapeutics，使該公司能夠在全國範圍內監督其供應與推廣。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4539":"次新股","BK4139":"生物科技","PTHS":"PELTHOS THERAPEUTICS INC","BK4007":"制药","LENZ":"Therapeutics"},"translate_title":"Pelthos Therapeutics Secures Exclusive U.S. Marketing Rights for Xepi Cream","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PTHS":0.9,"LENZ":1.5},"content_text":"by GOAI由GOAI生成Share To分享到Pelthos Therapeutics has acquired the exclusive rights to market Xepi (ozenoxacin) Cream, 1%, in the United States. The product is a non-fluorinated quinolone antimicrobial cream designed for topical use. This agreement grants Pelthos control over the distribution and commercialization of Xepi within the U.S.Pelthos Therapeutics已獲得在美國市場銷售1% Xepi（奧澤諾沙星）乳膏的獨家權利。該產品是一種用於局部使用的非氟喹諾酮類抗菌藥膏。此協議授予Pelthos在美國境內對Xepi的分銷和商業化的控制權。market..市場。。Xepi Cream, which contains 1% ozenoxacin, is used as an antimicrobial treatment for skin infections. The acquisition involves transferring marketing rights from Biofrontera and Ferrer to Pelthos Therapeutics, allowing the company to oversee its availability and promotion across the country.含有1%奧澤諾沙星的Xepi乳膏被用作皮膚感染的抗菌治療。此次收購涉及將Xepi的營銷權從Biofrontera和Ferrer轉移至Pelthos Therapeutics，使該公司能夠在全國範圍內監督其供應與推廣。Newsflash | Powered by GeneOnline AI新聞快訊 | 由GeneOnline AI提供支持Source: GO-AI-ne1來源：GO-AI-ne1For any suggestion and feedback, please contact us.如有任何建議和反饋，請聯繫我們。Date: November 10, 2025日期：2025年11月10日Related posts:相關文章：Generic Drug Makers Optimize Supply Chains with Real-Time Monitoring via AI and IoT.通用藥物製造商通過人工智能和物聯網進行實時監控來優化供應鏈。Biopharma Industry Growth Drives Demand for Packaging That Ensures Stability and Sterility生物製藥行業的增長推動了對確保穩定性和無菌性的包裝的需求。Candidate Drug Found to Boost Protective Protein and Improve Memory in Mice with Alzheimer’s Disease阿爾茨海默病小鼠體內發現可增強保護性蛋白並改善記憶的候選藥物Eight Horror Films to Premiere on Major Streaming Platforms in October 20252025年10月，八大恐怖電影將在主流流媒體平台首映。©www.geneonline.com All rights reserved. Collaborate with us:©www.geneonline.com 保留所有權利。與我們合作：[email protected]電子郵件地址Author作者GOAIGOAIRelated Post相關文章News Flash新聞快訊SanegeneBio and Eli Lilly Partner to Develop RNAi Therapeutics for Metabolic Diseases賽諾基因生物與禮來合作開發針對代謝疾病的RNAi療法2025-11-102025年11月10日","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}